Exit Load
- In respect of each purchase/switch-in of units, an Exit load of 1% is payable if units are redeemed /switched-out within 30 days from the date of allotment.
- No Exit Load is payable if units are redeemed / switched out after 30 days from the date of allotment.
Performance
| Scheme Returns (%) | |
| Benchmark Returns (%)# | |
| Additional Benchmark Returns (%)## | |
| Value of Investment of Rs 10,000 | |
| Scheme Returns (Rs.) | |
| Benchmark (Rs.)# | |
| Additional Benchmark (Rs.)## | |
- ^Past performance may or may not be sustained in future and is not a guarantee of any future returns. # BSE Healthcare Index TRI #...Read More
Fund Managers
Mr. Nikhil Mathur
Fund Manager and Senior Equity Analyst
OVERSEAS
Mr. Dhruv Muchhal
Equity Analyst and Fund Manager for Overseas Investments
Top 10 Holdings
As on 30 Jun 2025
Downloads
HDFC Pharma and Healthcare Fund
SID - HDFC Pharma and Healthcare Fund dated May 30, 2025
KIM - HDFC Pharma and Healthcare Fund dated May 30, 2025
Presentation
Leaflet
Product Labelling
Benchmark Riskometer
This product is suitable for investors who are seeking~
- To generate long-term capital appreciation
- Investment predominantly in equity & equity related instruments of Pharma and healthcare companies
~Investors should consult their financial advisers, if in doubt about whether the product is suitable for them.
The Scheme being sectoral in nature carries higher risks versus diversified equity mutual funds on account of concentration and sector specific risks.
FAQs
1. What is HDFC Pharma and Healthcare Fund?
An open-ended equity scheme investing in Pharma and healthcare companies.
Investment Objective of the scheme - To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
There is no assurance that the investment objective of the Scheme will be achieved.
2. Is this fund suitable for conservative investors?
This product is suitable for investors who are seeking~
• To generate long-term capital appreciation
• Investment predominantly in equity & equity related instruments of Pharma and healthcare companies.
~ Investors should consult their financial advisers, if in doubt about whether the product is suitable for them.
The Scheme being thematic / sectoral in nature carries higher risks versus diversified equity mutual funds on account of concentration and theme / sector specific risks.
3. Can I start investing with a small amount in this fund?
The minimum application amount/ switch in is Rs.100/- and any amount thereafter
4. What is the exit load of the fund?
Exit Load:
• In respect of each purchase / switch-in of Units, an Exit Load of 1% is payable if Units are redeemed/ switched-out within 30 days from the date of allotment.
• No Exit Load is payable if Units are redeemed / switched-out after 30 days from the date of allotment.
In respect of Systematic Transactions such as SIP, STPs etc., Exit Load, if any, prevailing on the date of registration / enrolment shall be levied.
5. Does this fund invest in global healthcare companies?
Percentage of exposure to Overseas Securities will be upto 20% of the net assets.
This is an indicative value (Actual instrument/percentages may vary subject to applicable SEBI circulars)